Jonathan Goldsmith, Associate Director for Rare Diseases, Center for Drug Evaluation & Research
Theresa Mullin, Director, Office of Strategic Programs, CDER
Meghana Chalasani, Office of Strategic Programs, CDER
Christine Mueller, Medical Officer, Office of Orphan Product Development
Tejashri Purohit-Sheth, Director, Division of Clinical Evaluation & Pharmacology / Toxicology, CBER
Diane Maloney, Associate Director for Policy, Center for Biologics Evaluation & Research
Wilson Bryan, Director, Office of Tissues and Advanced Therapies, CBER
Ross Pierce, Medical Officer, Clinical Review Branch, Division of Hematology, CBER
Larissa Lapteva, Associate Director, Division of Clinical Evaluation & Pharmacology / Toxicology, CBER
Donna Lipscomb, Office of Communication, Outreach and Development, CBER (facilitator)

Hereditary Angioedema Patients Urge Work On Dosing, Product Shortages

More from Rare Diseases